ArticleEnvironment & health (Washington, D.C.)2025
Exposure Levels and Health Risks of Phthalate Alternatives: A Urinary Metabolite Study.
Article in Environment & health (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phthalate alternatives are increasingly replacing traditional phthalates (PAEs) as plasticizers due to growing regulatory and health concerns. However, these alternatives and their metabolites have been detected in both environmental and biological matrices, raising concerns regarding potential health risks. Here, we used ultrahigh performance liquid chromatography-tandem mass spectrometry to detect nine metabolites of four PAE alternatives (aPAEs) in 176 urine samples collected from residents of Chengdu and Suining, Sichuan Province, China. Our results revealed that seven metabolites were commonly present in the urine samples, with total metabolite concentrations ranging from 2.52 to 6300 ng/mL. The median concentrations were 21.1 ng/mL in Chengdu and 39.8 ng/mL in Suining. The compositional profiles of these metabolites in urine samples from both cities were similar, with mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) identified as the predominant metabolite, representing over 50% of the total concentration. Notably, teenagers exhibited higher exposure levels compared to other age groups. Despite these findings, the estimated internal exposures remained well below health-based guidance values and toxicological reference levels, suggesting that the current exposure level may not pose acute health risks. This study highlights the widespread occurrence of aPAE metabolites in human urine and underscores continued biomonitoring and risk assessment of these emerging pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.